Cargando…
Atrial fibrillation incidence in SARS-CoV-2 infected patients: Predictors and relationship with in-hospital mortality
Autores principales: | , , , , , , , , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Published by Elsevier B.V.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9425751/ http://dx.doi.org/10.1016/j.atherosclerosis.2022.06.769 |
_version_ | 1784778517530017792 |
---|---|
author | Maloberti, A. Giannattasio, C. Rebora, P. Occhino, G. Ughi, N. Rizzo, J. Fabbri, S. Leidi, F. Cartella, I. Algeri, M. Scarpellini, S. Rossetti, C. Epis, O.M. Molon, G. Bonfanti, P. Valsecchi, M.G. Genovesi, S. |
author_facet | Maloberti, A. Giannattasio, C. Rebora, P. Occhino, G. Ughi, N. Rizzo, J. Fabbri, S. Leidi, F. Cartella, I. Algeri, M. Scarpellini, S. Rossetti, C. Epis, O.M. Molon, G. Bonfanti, P. Valsecchi, M.G. Genovesi, S. |
author_sort | Maloberti, A. |
collection | PubMed |
description | |
format | Online Article Text |
id | pubmed-9425751 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2022 |
publisher | Published by Elsevier B.V. |
record_format | MEDLINE/PubMed |
spelling | pubmed-94257512022-08-30 Atrial fibrillation incidence in SARS-CoV-2 infected patients: Predictors and relationship with in-hospital mortality Maloberti, A. Giannattasio, C. Rebora, P. Occhino, G. Ughi, N. Rizzo, J. Fabbri, S. Leidi, F. Cartella, I. Algeri, M. Scarpellini, S. Rossetti, C. Epis, O.M. Molon, G. Bonfanti, P. Valsecchi, M.G. Genovesi, S. Atherosclerosis Article Published by Elsevier B.V. 2022-08 2022-08-30 /pmc/articles/PMC9425751/ http://dx.doi.org/10.1016/j.atherosclerosis.2022.06.769 Text en Copyright © 2022 Published by Elsevier B.V. Since January 2020 Elsevier has created a COVID-19 resource centre with free information in English and Mandarin on the novel coronavirus COVID-19. The COVID-19 resource centre is hosted on Elsevier Connect, the company's public news and information website. Elsevier hereby grants permission to make all its COVID-19-related research that is available on the COVID-19 resource centre - including this research content - immediately available in PubMed Central and other publicly funded repositories, such as the WHO COVID database with rights for unrestricted research re-use and analyses in any form or by any means with acknowledgement of the original source. These permissions are granted for free by Elsevier for as long as the COVID-19 resource centre remains active. |
spellingShingle | Article Maloberti, A. Giannattasio, C. Rebora, P. Occhino, G. Ughi, N. Rizzo, J. Fabbri, S. Leidi, F. Cartella, I. Algeri, M. Scarpellini, S. Rossetti, C. Epis, O.M. Molon, G. Bonfanti, P. Valsecchi, M.G. Genovesi, S. Atrial fibrillation incidence in SARS-CoV-2 infected patients: Predictors and relationship with in-hospital mortality |
title | Atrial fibrillation incidence in SARS-CoV-2 infected patients: Predictors and relationship with in-hospital mortality |
title_full | Atrial fibrillation incidence in SARS-CoV-2 infected patients: Predictors and relationship with in-hospital mortality |
title_fullStr | Atrial fibrillation incidence in SARS-CoV-2 infected patients: Predictors and relationship with in-hospital mortality |
title_full_unstemmed | Atrial fibrillation incidence in SARS-CoV-2 infected patients: Predictors and relationship with in-hospital mortality |
title_short | Atrial fibrillation incidence in SARS-CoV-2 infected patients: Predictors and relationship with in-hospital mortality |
title_sort | atrial fibrillation incidence in sars-cov-2 infected patients: predictors and relationship with in-hospital mortality |
topic | Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9425751/ http://dx.doi.org/10.1016/j.atherosclerosis.2022.06.769 |
work_keys_str_mv | AT malobertia atrialfibrillationincidenceinsarscov2infectedpatientspredictorsandrelationshipwithinhospitalmortality AT giannattasioc atrialfibrillationincidenceinsarscov2infectedpatientspredictorsandrelationshipwithinhospitalmortality AT reborap atrialfibrillationincidenceinsarscov2infectedpatientspredictorsandrelationshipwithinhospitalmortality AT occhinog atrialfibrillationincidenceinsarscov2infectedpatientspredictorsandrelationshipwithinhospitalmortality AT ughin atrialfibrillationincidenceinsarscov2infectedpatientspredictorsandrelationshipwithinhospitalmortality AT rizzoj atrialfibrillationincidenceinsarscov2infectedpatientspredictorsandrelationshipwithinhospitalmortality AT fabbris atrialfibrillationincidenceinsarscov2infectedpatientspredictorsandrelationshipwithinhospitalmortality AT leidif atrialfibrillationincidenceinsarscov2infectedpatientspredictorsandrelationshipwithinhospitalmortality AT cartellai atrialfibrillationincidenceinsarscov2infectedpatientspredictorsandrelationshipwithinhospitalmortality AT algerim atrialfibrillationincidenceinsarscov2infectedpatientspredictorsandrelationshipwithinhospitalmortality AT scarpellinis atrialfibrillationincidenceinsarscov2infectedpatientspredictorsandrelationshipwithinhospitalmortality AT rossettic atrialfibrillationincidenceinsarscov2infectedpatientspredictorsandrelationshipwithinhospitalmortality AT episom atrialfibrillationincidenceinsarscov2infectedpatientspredictorsandrelationshipwithinhospitalmortality AT molong atrialfibrillationincidenceinsarscov2infectedpatientspredictorsandrelationshipwithinhospitalmortality AT bonfantip atrialfibrillationincidenceinsarscov2infectedpatientspredictorsandrelationshipwithinhospitalmortality AT valsecchimg atrialfibrillationincidenceinsarscov2infectedpatientspredictorsandrelationshipwithinhospitalmortality AT genovesis atrialfibrillationincidenceinsarscov2infectedpatientspredictorsandrelationshipwithinhospitalmortality |